Bone regeneration firm Osteopore moving into China with Shanghai-listed Kontour Xi’an
After winning Hong Kong regulatory approvals last December, Osteopore is boosting its Chinese sales
Wed 24 Aug 22, 3:35pm (AEST)
Stock prices will auto-update without reloading the page. How it works:
More about Cboe Live pricing.
After winning Hong Kong regulatory approvals last December, Osteopore is boosting its Chinese sales
Other Markets News